Circulating tumor DNA as a prognostic marker in high-risk endometrial cancer

BACKGROUND: Currently, there is no reliable blood-based marker to track tumor recurrence in endometrial cancer (EC) patients. Liquid biopsies, specifically, circulating tumor DNA (ctDNA) analysis emerged as a way to monitor tumor metastasis. The objective of this study was to examine the feasibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Weiwei, Jia, Nan, Jiao, Haining, Chen, Jun, Chen, Yan, Zhang, Yueru, Zhu, Menghan, Zhu, Chongying, Shen, Lifei, Long, Wenqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860194/
https://www.ncbi.nlm.nih.gov/pubmed/33536036
http://dx.doi.org/10.1186/s12967-021-02722-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860194/
https://www.ncbi.nlm.nih.gov/pubmed/33536036
http://dx.doi.org/10.1186/s12967-021-02722-8

Ejemplares similares